Form 10-Q INOTEK PHARMACEUTICALS For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Inotek Pharma (ITEK) Posts Narrwer-than-Expected Q1 Loss of 21c/Share
May 15, 2015 8:25 AM EDTInotek Pharma (NASDAQ: ITEK) reported Q1 EPS of ($0.21), $0.19 better than the analyst estimate of ($0.40).
Cash and cash equivalents as of March 31, 2015 were $53.1 million, compared to $3.6 million as of December 31, 2014.
For earnings history and earnings-related data on Inotek Pharma (ITEK) click here.
... More


